Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DANCE: Short vs Standard Course Antibiotics for Cellulitis
NCT02032654Phase 4Terminated
- Sponsor
- University of Amsterdam
- Start
- Aug 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of flucloxacillin in cellulitis and erysipelas (2 arms), sponsored by University of Amsterdam. Primary endpoints: Resolution of cellulitis at 14 days and Resolution of cellulitis without relapse at 28 days. Started Aug 2014; status: terminated.
02
Drugs
flucloxacillin
03
Conditions
cellulitiserysipelas
Beyond the preview
Go deeper on NCT02032654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032654.